Literature DB >> 17251409

Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.

Girum Shiferaw1, Yimtubezinash Woldeamanuel, Mekdes Gebeyehu, Feven Girmachew, Daniel Demessie, Eshetu Lemma.   

Abstract

Early detection of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) is of primary importance for both patient management and infection control. Optimal methods for identifying drug-resistant Mycobacterium tuberculosis in a timely and affordable way in resource-limited settings are not yet available. This study prospectively evaluated a low-technology but rapid drug susceptibility testing method, the microscopic observation drug susceptibility assay (MODS), in the concurrent detection of M. tuberculosis and its susceptibilities to isoniazid and rifampin (two drugs defining multidrug-resistant M. tuberculosis) directly from sputum specimens. Sputum samples were collected from 262 smear-positive TB patients in Addis Ababa, Ethiopia. To undertake MODS, 100 mul of decontaminated samples was inoculated into a 24-well plate containing 1 ml of 7H9 broth with and without appropriate drugs. The assay uses an inverted-light microscope to detect characteristic mycobacterial growth in liquid culture. Of 262 smear-positive patients, MODS detected 254 (96.9%) and culture in Löwenstein-Jensen medium detected 247 (94.3%) (P = 0.016). For the 247 cultures, the sensitivity, specificity, and accuracy of MODS for detecting MDR-TB were 92.0, 99.5, and 98.8%, respectively, using the method of proportion as a reference (concordance, 98.8%; kappa value, 0.932). Results for MODS were obtained in a median time of 9 days. MODS is an optimal alternative method for identifying MDR-TB in a timely and affordable way in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251409      PMCID: PMC1865834          DOI: 10.1128/JCM.01949-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital.

Authors:  V Goloubeva; M Lecocq; P Lassowsky; F Matthys; F Portaels; I Bastian
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.

Authors:  Walter G Park; William R Bishai; Richard E Chaisson; Susan E Dorman
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Evaluation of a PCR-based universal heteroduplex generator assay as a tool for rapid detection of multidrug-resistant Mycobacterium tuberculosis in Peru.

Authors:  Holger Mayta; Robert H Gilman; Fanny Arenas; Teresa Valencia; Luz Caviedes; Sonia H Montenegro; Eduardo Ticona; Jaime Ortiz; Rosa Chumpitaz; Carlton A Evans; Diana L Williams
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis.

Authors:  Getahun Abate; Abraham Aseffa; Alemayehu Selassie; Solomon Goshu; Bekele Fekade; Dawit WoldeMeskal; Håkan Miörner
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay.

Authors:  Isik Somuncu Johansen; Bettina Lundgren; Anaida Sosnovskaja; Vibeke Østergaard Thomsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

6.  Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay.

Authors:  K A Kristian Angeby; Lisbeth Klintz; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis.

Authors:  Luz Caviedes; Jose Delgado; Robert H Gilman
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

8.  Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru.

Authors:  L Caviedes; T S Lee; R H Gilman; P Sheen; E Spellman; E H Lee; D E Berg; S Montenegro-James
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Authors:  Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

10.  Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures.

Authors:  H Syre; S Phyu; P Sandven; B Bjorvatn; H M S Grewal
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more
  23 in total

1.  A comparison of the Sensititre® MYCOTB panel and the agar proportion method for the susceptibility testing of Mycobacterium tuberculosis.

Authors:  M M Abuali; R Katariwala; V J LaBombardi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-25       Impact factor: 3.267

2.  Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis.

Authors:  Julianna Cordova; Ron Shiloh; Robert H Gilman; Patricia Sheen; Laura Martin; Fanny Arenas; Luz Caviedes; Vivian Kawai; Giselle Soto; Diana L Williams; Mirko Zimic; A Roderick Escombe; Carlton A Evans
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

3.  Reliability of the MODS assay decentralisation process in three health regions in Peru.

Authors:  A Mendoza; E Castillo; N Gamarra; T Huamán; M Perea; Y Monroi; R Salazar; J Coronel; M Acurio; G Obregón; M Roper; C Bonilla; L Asencios; D A J Moore
Journal:  Int J Tuberc Lung Dis       Date:  2011-02       Impact factor: 2.373

4.  MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus.

Authors:  J Coronel; M Roper; S Mitchell; E Castillo; N Gamarra; F Drobniewski; G Luna; A Mendoza; D A J Moore
Journal:  Int J Tuberc Lung Dis       Date:  2010-11       Impact factor: 2.373

5.  Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.

Authors:  Krishna P Reddy; Mark F Brady; Robert H Gilman; Jorge Coronel; Marcos Navincopa; Eduardo Ticona; Gonzalo Chavez; Eduardo Sánchez; Christian Rojas; Lely Solari; Jorge Valencia; Yvett Pinedo; Carlos Benites; Jon S Friedland; David A J Moore
Journal:  Clin Infect Dis       Date:  2010-04-01       Impact factor: 9.079

6.  Training laboratory technicians from the Ethiopian periphery in the MODS technique enables rapid and low-cost diagnosis of Mycobacterium tuberculosis infection.

Authors:  Hila Elinav; Henry D Kalter; Luz Caviedes; Lawrence H Moulton; Eshetu Lemma; Andrea Rajs; Colin Block; Shlomo Maayan
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 7.  Alternative methods of diagnosing drug resistance--what can they do for me?

Authors:  David A J Moore; N Sarita Shah
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

8.  Development of low-cost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture.

Authors:  Mirko Zimic; Abner Velazco; Germán Comina; Jorge Coronel; Patricia Fuentes; Carmen G Luna; Patricia Sheen; Robert H Gilman; David A J Moore
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

9.  The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis.

Authors:  Mark F Brady; Jorge Coronel; Robert H Gilman; David Aj Moore
Journal:  J Vis Exp       Date:  2008-08-11       Impact factor: 1.355

Review 10.  Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.

Authors:  Louis Grandjean; David A J Moore
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.